Fresenius Medical Care AG reports results for the quarter ended September 30 - Earnings Summary

• Fresenius Medical Care AG reported quarterly adjusted earnings of 56 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 55 cents. The mean expectation of two analysts for the quarter was for earnings of 53 cents per share. Wall Street expected results to range from 51 cents to 55 cents per share.

• Revenue rose 1.1% to €4.94 billion from a year ago; analysts expected €4.86 billion.

• Fresenius Medical Care AG's reported EPS for the quarter was 31 cents​.

• Fresenius Medical Care AG shares had risen by 1.0% this quarter and lost 5.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.8% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "sell" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and 4 "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is "buy."

• Wall Street's median 12-month price target for Fresenius Medical Care AG is $22.08, about 2.4% below its last closing price of $22.61

This summary was machine generated from LSEG data November 3 at 07:37 a.m. UTC. ​All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)